Safety and immunogenicity of BBV152 (COVAXIN) SARS-CoV-2 Vaccine: Part 1- Vaccine basics

Inactivated Vaccines

Inactivated vaccines are usually made by exposing virulent virus to chemical or physical agents like formalin or beta-propiolactone to destroy infectivity while retaining immunogenicity.

The chemical or physical treatment used to eliminate infectivity of inactivated virus vaccines may be damaging enough to modify immunogenicity, particularly of antigens needed to elicit cell-mediated immune responses. The result is an immune response that is shorter in duration, narrower in spectrum for viral antigens, weaker cell-mediated and mucosal immune responses, and probably less effective in preventing viral entry.

Therefore, such vaccines need to use large amounts of antigen to elicit an adequate antibody response– a major disadvantage.

1 thought on “Safety and immunogenicity of BBV152 (COVAXIN) SARS-CoV-2 Vaccine: Part 1- Vaccine basics

  1. Pingback: Safety and immunogenicity of BBV152 (COVAXIN) SARS-CoV-2 Vaccine: Part 3- Study Results | communitymedicine4all

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.